Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Mebendazole 100mg price?
Alogliptin benz cost?
When will generic fiasap insulin be available?
Novartis patent term dabrafenib?
Norcuron generic name?

Fresenius kabi dilaudid vs. rhodes?

See the DrugPatentWatch profile for dilaudid

Fresenius Kabi Dilaudid vs. Rhodes Hydromorphone – a quick comparison

Feature Fresenius Kabi Dilaudid Rhodes Hydromorphone
Active ingredient Hydromorphone hydrochloride (base) Hydromorphone hydrochloride
Formulation Injectable solution (1 mg/mL in 5 mL vials, 2 mg/mL in 10 mL vials) Injectable solution (1 mg/mL in 5 mL vials, 2 mg/mL in 10 mL vials)
Excipients Water for injection, sodium chloride, sodium hydroxide, hydrochloric acid, polysorbate 80 (in some preparations) Similar excipients; exact composition varies by manufacturer, but usually water for injection, sodium chloride, and pH‑adjusting agents
Regulatory status (US) FDA‑approved brand name (approved 2001) Not FDA‑approved; available in other markets (e.g., India, Middle East, parts of Latin America)
Pricing (US) Generally higher due to brand premium (~$150–$200 per vial for 2 mg/mL) Lower cost (generic equivalent, often <$30–$50 per vial for 2 mg/mL)
Availability Widely available in hospitals and specialty pharmacies across the US Limited in the US (mostly via import or specialized compounding); widely available in countries where the brand is registered
Packaging 5 mL vials (1 mg/mL) or 10 mL vials (2 mg/mL) Same vial sizes, but packaging may differ (e.g., different labeling, packaging materials)
Dosing guidance 1–4 mg IV/SC every 4–6 h PRN; titrate to effect; max 12 mg/day for chronic pain (if IV) Same dosing range; clinicians can use the same titration strategy as Dilaudid
Side‑effect profile Typical opioid side effects: respiratory depression, constipation, nausea, sedation, pruritus Same profile; no clinically significant differences between brands
Special considerations Approved for use in patients with renal impairment (dose adjustment: 50–75 % of usual dose); product label includes renal dosing guidelines Similar renal dose adjustments apply; always check the specific label for the manufacturer’s recommendations
Key differences Brand name, price, regulatory approval in the US, and small differences in excipient composition Brand name, price (generally lower), and availability outside the US; formulation is essentially the same active ingredient

Why the two names matter

  1. Same active drug, same pharmacology
    Hydromorphone is a potent μ‑opioid receptor agonist. Whether you get it from Fresenius Kabi or from Rhodes, the mechanism of action, the equianalgesic potency (1 mg hydromorphone ≈ 10–12 mg oral morphine), and the risk profile remain the same.

  2. Cost & insurance coverage
    In the United States, Fresenius Kabi’s Dilaudid is a brand‑name drug and is often not covered by all insurers, or it comes with a higher copay. Rhodes, being a generic‑equivalent brand used in other markets, is usually cheaper but may not be listed on US formularies.

  3. Regulatory oversight
    Dilaudid is FDA‑approved, which means it has undergone the full FDA review process. Rhodes is approved in other jurisdictions but is not FDA‑approved, so it may not meet the same labeling or post‑market surveillance requirements that US‑approved drugs do.

  4. Excipients & patient safety
    Small differences in excipients can matter for patients with sensitivities (e.g., to polysorbate 80 or sodium). If a patient has a known allergy to a particular excipient, it’s important to check the specific label of the product you’re prescribing.

Practical tips for clinicians

Situation Recommendation
Switching a patient from Dilaudid to Rhodes No dose conversion needed—same strength. Keep a record of the exact vial concentration to avoid errors.
Managing renal impairment Follow the renal dosing guidance on the label of the specific product you’re using. For Dilaudid, reduce the dose by 25–50 % in patients with CrCl < 30 mL/min. The same applies to Rhodes.
Insurance coverage issues Check the patient’s formulary. If Dilaudid isn’t covered, a generic hydromorphone (often labeled “hydromorphone” without a brand name) can be used as a cost‑effective alternative.
Patient education Emphasize the risk of respiratory depression, especially in the first 24 h of therapy or when increasing the dose. Encourage use of a rescue medication (e.g., naloxone) and monitoring for sedation.
Compounding or import If you must import Rhodes or another brand, confirm that the importation complies with local regulations (e.g., FDA import rules) and that the vial has a valid expiration date.

Bottom line

  • Pharmacologically, Fresenius Kabi Dilaudid and Rhodes hydromorphone are identical; they contain the same active drug and have the same therapeutic and adverse‑effect profiles.
  • Practically, the choice between them comes down to cost, availability, and regulatory status. In the US, Fresenius Kabi’s product is the only brand‑approved option. In other countries, Rhodes (or other generic brands) may be the preferred or only available choice.
  • Clinical decision: Use the brand that is covered by the patient’s insurance and available in the local formulary, but be mindful of excipient differences and dosing guidelines. Always titrate carefully and monitor for opioid‑related side effects.

If you need more specific data—such as exact excipient lists, vial labeling, or country‑specific regulatory approvals—feel free to let me know, and I can dig deeper!



Other Questions About Dilaudid :

dilaudid 1 mg iv When did the patent on dilaudid expire? Dilaudid patent? Dilaudid street price? Dilaudid im? Price of dilaudid? Street value of dilaudid?